Y-T Tai

KDM6B modulates MAPK pathway mediating multiple myeloma cell growth and survival

Hiroto Ohguchi, Takeshi Harada, M. Sagawa et al. · Leukemia · 2017 · 97 citations

Hematological Malignancy, Tumor Biology, Cell Regulation +9

Protein arginine methyltransferase 5 has prognostic relevance and is a druggable target in multiple myeloma

Annamaria Gullà, Teru Hideshima, Giada Bianchi et al. · Leukemia · 2017 · 97 citations · Full text

Hematological Malignancy, Druggable Target, Medicine +10

HDAC inhibition by LBH589 affects the phenotype and function of human myeloid dendritic cells

Wei Song, Y-T Tai, Zhouyang Tian et al. · Leukemia · 2010 · 96 citations · Full text

Class IIa HDAC inhibition enhances ER stress-mediated cell death in multiple myeloma

Shohei Kikuchi, Rikio Suzuki, Hiroto Ohguchi et al. · Leukemia · 2015 · 88 citations

Hematological Malignancy, Tumor Biology, Medicine +8

Nucleotide excision repair is a potential therapeutic target in multiple myeloma

Raphaël Szalat, Mehmet Samur, Mariateresa Fulciniti et al. · Leukemia · 2017 · 56 citations · Full text

Potential Therapeutic Target, Hematological Malignancy, Genome Instability +13